Ying‐Tzu Chang

ORCID: 0009-0007-9913-1041 · 1 paper in corpus
article 2019
Scientific reports ·doi:10.1038/s41598-019-48169-2

Multidrug resistance presents an obstacle in cancer treatment. Among numerous combative strategies, collateral sensitivity (CS) drugs have opened a new avenue to defeat cancer by exploiting selective toxicity against multidrug-resistant (MD…